Pliant Therapeutics Inc

PLRX

Company Profile

  • Business description

    Pliant Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of integrin-based therapies. The company operates as a single reportable segment focused on developing and commercializing novel integrin-based treatments. Its lead product candidate, PLN-101095, is an oral small molecule targeting integrins for the treatment of solid tumors. The company also advances a pipeline of integrin-based programs across multiple disease areas through its proprietary drug discovery platform.

  • Contact

    331 Oyster Point Boulevard
    South San FranciscoCA94080
    USA

    T: +1 650 481-6770

    https://www.pliantrx.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    31 December 2026

    Employees

    49

Stocks News & Analysis

stocks

The 5 best US dividend aristocrats to watch in 2026

How to avoid the dividend aristocrat trap.
stocks

Chart of the Week: Is CSL finally turning the ship around?

The beaten down healthcare giant remains cheap on turnaround potential.
stocks

ASX top pick remains cheap with narrowing brand focus

Shares remain cheap for ASX winemaker as the company narrows focus on high margin brands.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,836.7071.200.81%
CAC 408,200.8038.970.48%
DAX 4024,209.7114.400.06%
Dow JONES (US)50,231.94313.160.63%
FTSE 10010,303.8849.070.48%
HKSE24,249.29158.67-0.65%
NASDAQ25,309.49139.990.56%
Nikkei 22564,217.2738.000.06%
NZX 50 Index13,202.1651.49-0.39%
S&P 5007,291.8624.870.34%
S&P/ASX 2008,633.2069.700.81%
SSE Composite Index3,987.016.21-0.16%

Market Movers